MEKK1 Antibody [B14N1] Datasheet

Biological Description

Specificity	MEKK1 Antibody [B14N1] detects endogenous levels of total MEKK1 protein.
Background	MEKK1, also termed MAP3K1, is a MAP kinase kinase kinase that links receptors for growth factors, cytokines, and stress signals to downstream MAPK and NF‑κB pathways through its dual functions as a serine/threonine protein kinase and a RING/PHD‑type E3 ubiquitin ligase. The protein contains an N‑terminal regulatory and scaffold region with multiple docking motifs, a central plant homeodomain (PHD) finger with RING‑like E3 ligase activity, and a C‑terminal kinase domain that phosphorylates specific MAP2Ks, including MEK1/2 (MAP2K1/2) and MKK4/7 (MAP2K4/7), which in turn activate ERK1/2 and JNK MAPKs. MEKK1 associates with upstream adaptors such as TRAF2, Grb2, and small GTPases and is recruited to receptor complexes downstream of TNF receptor family members, T‑cell receptor, EGFR, and TGFβ receptors; within these complexes, MEKK1 functions as both a scaffold and a catalytic kinase that organizes and activates ERK and JNK cascades in response to mitogenic and stress signals. The kinase also contributes to NF‑κB pathway activation by phosphorylating components upstream of the IKK complex and by participating in signaling to AP‑1 and NF‑κB transcription factors under conditions such as TNFα stimulation and osmotic or cytoskeletal stress. The PHD/RING domain of MEKK1 acts as an E3 ligase that interacts with ubiquitin‑conjugating enzymes, including UBE2D family members and UBE2N complexes, and catalyzes ubiquitination of substrates such as c‑Jun and other signaling proteins, which modulates their stability and activity and is required together with the kinase domain for full MAPK activation. MEKK1 is proteolytically cleaved by caspases during Fas‑ and stress‑induced apoptosis, generating an active kinase fragment that translocates and amplifies JNK and stress‑activated pathway signaling, linking caspase activation to MAPK‑driven apoptotic programs. MEKK1 regulates cell survival during hyperosmotic and microtubule-disrupting stress. MEKK1 also controls C/EBPβ-dependent transcription in response to interferon-γ and represses promoters like PKD1 through interactions with promoter-bound p53.

Specificity

MEKK1 Antibody [B14N1] detects endogenous levels of total MEKK1 protein.

Background

MEKK1, also termed MAP3K1, is a MAP kinase kinase kinase that links receptors for growth factors, cytokines, and stress signals to downstream MAPK and NF‑κB pathways through its dual functions as a serine/threonine protein kinase and a RING/PHD‑type E3 ubiquitin ligase. The protein contains an N‑terminal regulatory and scaffold region with multiple docking motifs, a central plant homeodomain (PHD) finger with RING‑like E3 ligase activity, and a C‑terminal kinase domain that phosphorylates specific MAP2Ks, including MEK1/2 (MAP2K1/2) and MKK4/7 (MAP2K4/7), which in turn activate ERK1/2 and JNK MAPKs. MEKK1 associates with upstream adaptors such as TRAF2, Grb2, and small GTPases and is recruited to receptor complexes downstream of TNF receptor family members, T‑cell receptor, EGFR, and TGFβ receptors; within these complexes, MEKK1 functions as both a scaffold and a catalytic kinase that organizes and activates ERK and JNK cascades in response to mitogenic and stress signals. The kinase also contributes to NF‑κB pathway activation by phosphorylating components upstream of the IKK complex and by participating in signaling to AP‑1 and NF‑κB transcription factors under conditions such as TNFα stimulation and osmotic or cytoskeletal stress. The PHD/RING domain of MEKK1 acts as an E3 ligase that interacts with ubiquitin‑conjugating enzymes, including UBE2D family members and UBE2N complexes, and catalyzes ubiquitination of substrates such as c‑Jun and other signaling proteins, which modulates their stability and activity and is required together with the kinase domain for full MAPK activation. MEKK1 is proteolytically cleaved by caspases during Fas‑ and stress‑induced apoptosis, generating an active kinase fragment that translocates and amplifies JNK and stress‑activated pathway signaling, linking caspase activation to MAPK‑driven apoptotic programs. MEKK1 regulates cell survival during hyperosmotic and microtubule-disrupting stress. MEKK1 also controls C/EBPβ-dependent transcription in response to interferon-γ and represses promoters like PKD1 through interactions with promoter-bound p53.

Usage Information

Application

WB, IP, IF

Dilution

WB	IF
1:100-1:1000	1:50-1:500

Reactivity

Mouse, Rat, Human

Source

Mouse Monoclonal Antibody

MW

164 kDa

Storage Buffer

PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage
(from the date of receipt)

-20°C (avoid freeze-thaw cycles), 2 years

References

https://pubmed.ncbi.nlm.nih.gov/9836645/
https://pubmed.ncbi.nlm.nih.gov/9689033/

MEKK1 Antibody [B14N1]

Biological Description

Usage Information

References

Application Data